Recombinant Proteins

Herpes Simplex Virus Type 2 Radiculomyelitis Disguised as Conversion Disorder.

Herpes Simplex Virus Type 2 Radiculomyelitis Disguised as Conversion Disorder.

Herpes simplex virus sort 2 (HSV-2) is the most typical reason behind genital herpes with a seroprevalence of 20-30% in developed nations and 80% worldwide. In addition to neonatal encephalitis
Therapeutic HSV-2 vaccine decreases recurrent virus shedding and recurrent genital herpes disease.

Therapeutic HSV-2 vaccine decreases recurrent virus shedding and recurrent genital herpes disease.

Genital herpes simplex virus (HSV) sort 2 is a standard persistent an infection that ceaselessly reactivates to trigger recurrent lesions and recurrent viral shedding which is incompletely managed
The cotton rat provides a novel model to study genital herpes infection and to evaluate preventive strategies.

The cotton rat provides a novel model to study genital herpes infection and to evaluate preventive strategies.

Prevention of genital herpes and different sexually transmitted infections (STI) is a crucial well being precedence due to the overwhelming influence on ladies and infants and the epidemiological
Progesterone increases susceptibility and decreases immune responses to genital herpes infection.

Progesterone increases susceptibility and decreases immune responses to genital herpes infection.

Depo-provera, a long-acting progestational formulation, is extensively used to facilitate an infection of sexually transmitted illnesses in animal fashions. We have beforehand reported that hormone
Virologic characteristics of subclinical and symptomatic genital herpes infections.

Virologic characteristics of subclinical and symptomatic genital herpes infections.

BACKGROUNDThe frequency, sample, and anatomical websites of subclinical shedding of herpes simplex virus (HSV) within the genital tract, together with elements that predict such shedding,
Once-daily valacyclovir to reduce the risk of transmission of genital herpes.

Once-daily valacyclovir to reduce the risk of transmission of genital herpes.

BACKGROUNDNucleoside analogues in opposition to herpes simplex virus (HSV) have been proven to suppress shedding of HSV kind 2 (HSV-2) on genital mucosal surfaces and should forestall sexual
Glycoprotein-D-adjuvant vaccine to prevent genital herpes.

Glycoprotein-D-adjuvant vaccine to prevent genital herpes.

BACKGROUND An efficient prophylactic vaccine would assist management the unfold of genital herpes.METHODSWe performed two double-blind, randomized trials of a herpes simplex virus kind 2 (HSV-2)